PharVision Advisers’s Masco MAS Stock Holding History

PharVision Advisers’s Portfolio MAS Stock Details MAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,566	Closed	-$353K	–	419
2025 Q4	$353K	Sell	5,566 -941	-14%	-$61.1K	0.18%	185
2025 Q3	$458K	Buy	+6,507	New	+$458K	0.26%	38

Other funds holding MAS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

PharVision Advisers's MAS Position: Q1 2026 in Review

PharVision Advisers sold out of Masco (MAS) in Q1 2026, closing a stake of 5,566 shares — an estimated $353K sold.

PharVision Advisers first reported a position in MAS in Q3 2025 and held it in 2 quarters. The position peaked at $458K in Q3 2025. 833 funds tracked by Wall St. Rank hold MAS as of Q1 2026.

PharVision Advisers reported no remaining Masco position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 5,566 Masco shares in Q1 2026, an estimated $353K.
PharVision Advisers first reported a position in Masco in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Masco position peaked at $458K in Q3 2025.
833 funds tracked by Wall St. Rank held Masco as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.